Cabot (NYSE:CBT – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Tuesday,Zacks.com reports.
Other equities research analysts have also issued research reports about the company. UBS Group lifted their price objective on Cabot from $65.00 to $74.00 and gave the company a “neutral” rating in a research note on Monday, January 12th. Jefferies Financial Group reaffirmed a “buy” rating and set a $81.00 price target on shares of Cabot in a research note on Thursday, January 8th. JPMorgan Chase & Co. lowered their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Finally, Mizuho upped their price target on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $72.25.
View Our Latest Stock Analysis on Cabot
Cabot Price Performance
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. During the same quarter last year, the business posted $1.80 earnings per share. Cabot’s revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, sell-side analysts predict that Cabot will post 7.57 EPS for the current fiscal year.
Institutional Trading of Cabot
Institutional investors have recently bought and sold shares of the company. Smartleaf Asset Management LLC lifted its stake in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 299 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new position in Cabot in the 2nd quarter valued at approximately $28,000. Parkside Financial Bank & Trust lifted its position in Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after acquiring an additional 189 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in Cabot by 227.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 298 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares in the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Articles
- Five stocks we like better than Cabot
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
